vimarsana.com

Page 30 - ஆய்வகம் நிறுவனம் ஆஃப் அமெரிக்கா ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Precision Medicine Market - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2021

Global Anatomic Pathology Market Grow at a CAGR of 8 53% Steadily Till the end of 2025

Global Anatomic Pathology Market Research Report and Forecast 2020-2025 is the latest report by Fior Markets which is the fastest growing market research company. The report provides a comprehensive scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportuniti.

Urine Cytology Market Overview, Dynamics, Growth Factors for Business Expansion, Key Companies, Trends and Forecast 2023

Pharmacovigilance Market Size to be Worth USD 12 48 Billion Growing at 22 1% CAGR till 2027; Industry Revenue, Statistics, Forecast by Emergen Research

Pharmacovigilance Market Size to be Worth USD 12 48 Billion Growing at 22 1% CAGR till 2027; Industry Revenue, Statistics, Forecast by Emergen Research
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

BIS Research Study Highlights the Global MRD Market to Reach $1 61 Billion by 2025

Share this article Share this article FREMONT, Calif., Jan. 13, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the title Global MRD Testing Market highlights that the market is projected to reach $1.61 billion by 2025. The study also highlights that the market is set to witness a CAGR of 15.64% during the period between 2020 and 2025. The growth is aided by factors including increasing research funding from the National Cancer Institute and rising incidence of hematologic malignancies, among others. Minimal residual disease (MRD) testing is an evolving testing regimen that has been driving initiatives in the management of hematological malignancy patients. It is currently one of the fastest-growing markets under the molecular diagnostics umbrella. MRD testing promises the integration of evolutionary molecular technologies into hematological malignancy care regimens, thereby driving tremendous growth in the overall hematological malignanc

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.